🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Development and Demonstration of a Precision Prevention and Treatment System for Colorectal Tubular Adenomas Lesions

Recruitingn/aAges 18 Years - anyAllRenmin Hospital of Wuhan University
NCT07073430 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study is a prospective,multi-center and observational clinical study.Investigators would like to innovatively construct a "trinity" database of colorectal tubular adenomas based on white light - magnifying chromo - pathological images.It simulates the decision - making logic of doctors, and based on the multimodal endoscopic LAFEQ method previously proposed, develop a multimodal deep - learning diagnostic model for colon adenomas and an interpretable risk prediction model for intestinal adenomas. While achieving high - precision auxiliary treatment decisions, clearly present the decision - making basis, and break through the limitation of poor interpretability of previous medical imaging AI models.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients aged ≥ 18 years, who need to undergo colonoscopy, regardless of gender. * Voluntarily sign the informed consent form * Promise to abide by the research procedures and cooperate in the implementation of the entire research process. Exclusion Criteria: * Patients who has a history of abdominal or pelvic surgery or radiotherapy in the past; * Patients who has definite active lower gastrointestinal bleeding. * Existing or suspected hereditary colorectal polyposis, inflammatory bowel disease; * Uncontrolled hypertension (systolic blood pressure \> 160 mmHg or diastolic blood pressure \> 95 mmHg after standardized treatment) * There is a history of stroke, coronary artery disease, or vascular disease; * Pregnant; * Intestinal preparation cannot be carried out.
💊

What it tests

  • AI models with NBI
📍

Where

1 site
Renmin Hospital of Wuhan University
Wuhan, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy